Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Adami

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Bone|November 4, 2025
Bone mineral density response to romosozumab in post-menopausal women: A prospective observational real-world studyEvelien Gielen, Nadjia Amini, Désirée Coppens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 19, 2025
Increase in Serum DKK1 Levels Attenuates the Anabolic Response to Romosozumab in Postmenopausal OsteoporosisGiovanni Adami, Filippo Montanari, Angelo Fassio, et al.
Calcified Tissue International|January 4, 2020
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot StudyAngelo Fassio, Giovanni Adami, Alessandro Giollo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2025
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal OsteoporosisGiovanni Adami, Francesco Pollastri, Angelo Fassio, et al.
Scientific Reports|October 11, 2023
Changes in bone turnover markers and bone modulators during abatacept treatmentGiovanni Adami, Giovanni Orsolini, Maurizio Rossini, et al.
Clinical Rheumatology|December 9, 2024
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot studyRiccardo Bixio, Francesca Mastropaolo, Matteo Appoloni, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 24, 2025
Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)Mariana Diz Lopes, Giovanni Orsolini, Isotta Galvagni, et al.
Therapeutic Advances in Musculoskeletal Disease|November 8, 2019
Balancing benefits and risks in the era of biologicsGiovanni Adami, Kenneth G Saag, Roland D Chapurlat, et al.
Bone|November 10, 2023
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide databaseGiovanni Adami, Davide Gatti, Maurizio Rossini, et al.
Arthritis Research & Therapy|June 4, 2021
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritisAlessandro Giollo, Giovanni Cioffi, Federica Ognibeni, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Bone|November 4, 2025
Bone mineral density response to romosozumab in post-menopausal women: A prospective observational real-world studyEvelien Gielen, Nadjia Amini, Désirée Coppens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 19, 2025
Increase in Serum DKK1 Levels Attenuates the Anabolic Response to Romosozumab in Postmenopausal OsteoporosisGiovanni Adami, Filippo Montanari, Angelo Fassio, et al.
Calcified Tissue International|January 4, 2020
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot StudyAngelo Fassio, Giovanni Adami, Alessandro Giollo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2025
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal OsteoporosisGiovanni Adami, Francesco Pollastri, Angelo Fassio, et al.
Scientific Reports|October 11, 2023
Changes in bone turnover markers and bone modulators during abatacept treatmentGiovanni Adami, Giovanni Orsolini, Maurizio Rossini, et al.
Clinical Rheumatology|December 9, 2024
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot studyRiccardo Bixio, Francesca Mastropaolo, Matteo Appoloni, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 24, 2025
Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)Mariana Diz Lopes, Giovanni Orsolini, Isotta Galvagni, et al.
Therapeutic Advances in Musculoskeletal Disease|November 8, 2019
Balancing benefits and risks in the era of biologicsGiovanni Adami, Kenneth G Saag, Roland D Chapurlat, et al.
Bone|November 10, 2023
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide databaseGiovanni Adami, Davide Gatti, Maurizio Rossini, et al.
Arthritis Research & Therapy|June 4, 2021
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritisAlessandro Giollo, Giovanni Cioffi, Federica Ognibeni, et al.
Pageof 15